- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Multiple Myeloma - Nonmyeloablative transplantation - Autologous Transplant - Graft versus myeloma
Total 48651 results
-
PETHEMA FoundationJanssen, LP; Adknoma Health ResearchRecruitingMultiple Myeloma | Non-eligible for Autologous Stem Cell Transplantation (ASCT)Spain
-
University of NebraskaRecruitingLymphoma | Multiple MyelomaUnited States
-
M.D. Anderson Cancer CenterRecruiting
-
M.D. Anderson Cancer CenterRecruiting
-
University of Alabama at BirminghamRecruitingMultiple MyelomaUnited States
-
University Hospital, Clermont-FerrandMinistry of Health, France; French Society of HematologyRecruitingLymphoma, Non-Hodgkin | Myelodysplastic Syndromes | Hodgkin Lymphoma | Chronic Lymphocytic Leukemia | Myeloma | Acute Leukemia in Remission | Myeloproliferative SyndromeFrance
-
PETHEMA FoundationGlaxoSmithKlineRecruitingMultiple MyelomaSpain
-
University Hospital, MontpellierRecruitingLymphoma | Multiple Myeloma | Olfactivo-gustatory Disorder | Haematological CancerFrance
-
Emory UniversityNational Cancer Institute (NCI); Gateway for Cancer ResearchRecruiting
-
VA Office of Research and DevelopmentRecruitingAutologous Hematopoietic Stem Cell TransplantUnited States
-
Medical College of WisconsinRecruitingMultiple Myeloma | SleepUnited States
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN); Blood...RecruitingRelapsing Multiple Sclerosis | Relapsing Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Centre Hospitalier Universitaire, AmiensUniversity Hospital, Rouen; University Hospital, CaenRecruitingQuality of Life | Physical Activity | Multiple MyelomaFrance
-
University of Turin, ItalyRecruiting
-
Loyola UniversityAmgenRecruiting
-
University of LeedsTakeda; Cancer Research UKRecruitingMultiple MyelomaUnited Kingdom
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)RecruitingDiffuse Large B-Cell Lymphoma | Acute Myeloid Leukemia | Recurrent Hodgkin Lymphoma | Acute Lymphoblastic Leukemia | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Myelodysplastic Syndrome | Recurrent Small Lymphocytic Lymphoma | Blastic Plasmacytoid Dendritic Cell Neoplasm | Prolymphocytic Leukemia and other conditionsUnited States
-
Ottawa Hospital Research InstituteRecruiting
-
St. Petersburg State Pavlov Medical UniversityActive, not recruiting
-
National Heart, Lung, and Blood Institute (NHLBI)National Cancer Institute (NCI); National Marrow Donor Program; Blood and Marrow...CompletedMultiple MyelomaUnited States
-
Case Comprehensive Cancer CenterWithdrawnMyeloma | Autologous TransplantUnited States
-
Janssen Research & Development, LLCActive, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingPlasma Cell MyelomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingPlasma Cell Myeloma | Plasma Cell LeukemiaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Plasma Cell Leukemia | Loss of Chromosome 17p | Autologous Hematopoietic Stem Cell Transplant RecipientUnited States
-
Memorial Sloan Kettering Cancer CenterJanssen PharmaceuticalsActive, not recruiting
-
Janssen Research & Development, LLCCompletedMultiple MyelomaCanada, United States, Czechia, Israel, Italy, Korea, Republic of, Brazil, United Kingdom, Japan, Taiwan, Australia, Poland, Spain, France, Russian Federation, Sweden, Ukraine, Greece
-
University of NebraskaTerminatedPlasma Cell MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
National Cancer Institute (NCI)Active, not recruitingSmoldering Multiple Myeloma | Refractory Multiple Myeloma | DS Stage I Multiple Myeloma | DS Stage II Multiple Myeloma | DS Stage III Multiple MyelomaUnited States
-
Nanjing University School of MedicineEnrolling by invitationAL Amyloidosis | Plasma Cell DyscrasiaChina
-
Hackensack Meridian HealthActive, not recruitingLymphoma | Multiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterAmgenCompletedMultiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin Lymphoma | HDT-AHCTUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
BioLineRx, Ltd.Active, not recruitingMultiple MyelomaUnited States, Spain, Hungary, Germany, Italy
-
Weill Medical College of Cornell UniversityCelgeneActive, not recruiting
-
Paul Richardson, MDM.D. Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Massachusetts... and other collaboratorsActive, not recruiting
-
Washington University School of MedicineBristol-Myers Squibb; CelgeneActive, not recruitingMultiple Myeloma in RelapseUnited States, Canada
-
Washington University School of MedicineThe Foundation for Barnes-Jewish Hospital; GlycoMimetics IncorporatedCompleted
-
University of ArizonaActive, not recruitingMultiple Myeloma | Stem Cell Transplant ComplicationsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRefractory Plasma Cell Myeloma | Plasmacytoma | Recurrent Plasma Cell Myeloma | Plasma Cell LeukemiaUnited States
-
SCRI Development Innovations, LLCBristol-Myers SquibbCompletedMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
University of Alabama at BirminghamJanssen Scientific Affairs, LLC; AmgenCompletedMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterJanssen Scientific Affairs, LLCActive, not recruitingMultiple Myeloma | AL AmyloidosisUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingPlasma Cell MyelomaUnited States
-
Maisonneuve-Rosemont HospitalCompletedMultiple Myeloma | High-Risk CancerCanada
-
Memorial Sloan Kettering Cancer CenterSpectrum Pharmaceuticals, IncActive, not recruitingMultiple Myeloma | AmyloidosisUnited States
-
Fondazione EMN Italy OnlusActive, not recruitingMultiple Myeloma | New Diagnosis TumorItaly
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States